Rencofilstat
HEPA-CRV431-207
Phase 2 small_molecule active
Quick answer
Rencofilstat for Nonalcoholic Steatohepatitis (NASH) is a Phase 2 program (small_molecule) at Hepion Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hepion Pharmaceuticals
- Indication
- Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active